Opinion

Video

Optimizing EoE Care in Pediatric Patients: Treatments and Shared Decision-Making

Mirna Chehade, MD, MPH, emphasizes the value of proton pump inhibitors, swallowed corticosteroids, and dietary restrictions as therapeutic options for pediatric patients with eosinophilic esophagitis (EoE), while underscoring the importance of shared decision-making to maintain adherence and achieve better outcomes.

This is a video synopsis/summary of an Insights involving Mirna Chehade, MD, MPH.

Chehade explores the role of proton pump inhibitors and oral glucocorticoids in treating pediatric eosinophilic esophagitis (EoE), emphasizing their necessity for long-term management. Treatment sequencing involves shared decision-making with parents and older children, ensuring better outcomes and adherence. Nonpharmacological options, such as dietary restriction therapies, require careful consideration based on factors like age, nutritional status, and social/financial support. Acceptance of multiple endoscopies is crucial for identifying trigger foods in remission. The discussion underscores the need for an individualized approach, balancing pharmacological and nonpharmacological options through effective shared decision-making in pediatric EoE treatment.

Video synopsis is AI-generated and reviewed by AJMC® editorial staff.

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
Justin Oldham, MD, MS, an expert on IPF
Justin Oldham, MD, MS, an expert on IPF
4 KOLs are featured in this series
4 KOLs are featured in this series
Justin Oldham, MD, MS, an expert on IPF
Justin Oldham, MD, MS, an expert on IPF
Justin Oldham, MD, MS, an expert on IPF
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo